Xyphos
Pre-clinicalAt Xyphos, we’re working to deliver flexible and adaptable cancer therapies with the potential to revolutionize cancer care.
Founded
2016
Focus
Cell & Gene Therapy
About
At Xyphos, we’re working to deliver flexible and adaptable cancer therapies with the potential to revolutionize cancer care.
Funding History
2Total raised: $105M
Series B$75MVersant VenturesMar 15, 2022
Series A$30MVersant VenturesSep 15, 2020
Company Info
TypePrivate
Founded2016
LocationSouth San Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile